BIOL

Biolase, Inc.
BIOL

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

28 hedge funds and large institutions have $6.17M invested in Biolase, Inc. in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
28
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$29.8K
2
+$18.4K
3
+$14.1K
4
Jane Street
Jane Street
New York
+$10K
5
Renaissance Technologies
Renaissance Technologies
New York
+$8.8K

Top Sellers

1
-$31K
2
-$27K
3
-$23K
4
VCM
Virtue Capital Management
Tennessee
-$14K
5
HF
HRT Financial
New York
-$12.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$3K
27
$1.06K
28
$1K
29
$141
30
–
31
–
32
–
33
–
34
–
35
–
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
1
2